Nuclear Medicine Market / Radiopharmaceuticals Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology,Thyroid, Oncology), Procedures, End User - Global Forecast to 2

Nuclear Medicine Market / Radiopharmaceuticals Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology,Thyroid, Oncology), Procedures, End User - Global Forecast to 2028



The global nuclear medicine market is projected to reach USD 9.4 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 11.3% during the forecast period. Growth in the nuclear medicine market can primarily be attributed to factors such as the increasing prevalence of CVD, government initiatives to improve healthcare, rapid growth in the geriatric population and the growing adoption of PET and SPECT techniques. However, the short half-life of radiopharmaceuticals decreases their potential adoption, and are expected to challenge market growth to a certain extent.

Therapeutic segment is projected to grow at the highest CAGR during the forecast period

By type, the nuclear medicine market is segmented into diagnostic and therapeutic. The therapeutic segment is projected to grow at the highest CAGR during the forecast period. This can be attributed to growing applications of these isotopes in oncology, as these isotopes have minimal side effects as opposed to surgeries and chemotherapy.

Hospital end user segment is projected to account for the largest share of the nuclear medicine market

By end user, thenuclear medicine market is segmented into the nuclear medicine market is segmented into hospitals, imaging centers, academic & research centers and other end users, which include pharma/biotech companies and contract research organizations. In 2023, the hospital segment isprojected to account for the largest share of the nuclear medicine market due to the growing focus on the automation & digitization of radiology patient workflows to improve the quality of patient care.

By region, North America is projected to account for the largest share of the nuclear medicine market

By region,North America accounted for the largest share of the nuclear medicine market in 2023. Factors such as rising prevalence of chronic diseases is expected to increase the number of diagnosis and treatment in this region, government funding, and company initiatives.

Breakdown of supply-side primary interviews:By Company Type: Tier 1 – 64%, Tier 2 – 23%, and Tier 3 – 13%By Designation: C-level – 35%, Director-level – 25%, and Others – 40%By Region: North America - 42%, Europe – 21%, APAC –26%, Rest of the World –11%

Some of the prominent players operating in the nuclear medicine market include GE HealthCare (US),Cardinal Health (US), Curium (France),Bayer AG (Germany), Lantheus Holdings, Inc.(US), Bracco Imaging S.p.A. (Italy), PharmaLogic Holdings Corp. (US), Eczacıbaşı-Monrol Nuclear Products (Turkey), NTP Radioisotopes SOC Ltd (South Africa), Nordion Inc.(Canada), Advanced Accelerator Applications (France), NorthStar Medical Radioisotopes (US), Eckert & Ziegler (Germany), Isotope JSC (Russia), Siemens Healthineers (Germany), Jubilant DraxImage,Inc. (Canada).

Research Coverage

This report studies the nuclear medicine market based on type, application, procedure volume, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

This report provides insights into the following pointers:

Analysis of key drivers (increasing incidence and prevalence of target conditions, development of alpha-radioimmunotherapy-based targeted cancer treatments, initiatives to reduce the demand and supply gap of Mo-99), restraints (Short half-life of radiopharmaceuticals),opportunities (use of radiopharmaceuticals in neurological applications and high growth opportunities in emerging countries) and challenges (hospital budget cuts and high equipment costs) influencing the growth of nuclear medicine market.

Market Penetration: Comprehensive information on product portfolios offered by the top players in the global nuclear medicine market . The report analyzes this market by type, application, procedure volume, end user, and region

Product Development/Innovation: Detailed insights on upcoming trends and product launches in the global nuclear medicine market

Market Development: Comprehensive information on the lucrative emerging markets by type, application, procedure volume, end user, and region

Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global nuclear medicine market

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global nuclear medicine market


  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
      • INCLUSIONS & EXCLUSIONS
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED
    • CURRENCY
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
    • RESEARCH METHODOLOGY STEPS
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
    • MARKET DATA ESTIMATION AND TRIANGULATION
    • STUDY ASSUMPTIONS
    • RISK ASSESSMENT
      • Table RISK ASSESSMENT: NUCLEAR MEDICINE MARKET
    • STUDY LIMITATIONS
    • NUCLEAR MEDICINE MARKET: RECESSION IMPACT
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • NUCLEAR MEDICINE MARKET OVERVIEW
    • NORTH AMERICA: NUCLEAR MEDICINE MARKET, BY TYPE AND COUNTRY (2022)
    • NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC PROCEDURES, BY TYPE, 2023 VS. 2028
    • NUCLEAR MEDICINE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • NUCLEAR MEDICINE MARKET, BY APPLICATION
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
        • Table PHYSICAL HALF-LIFE OF RADIOPHARMACEUTICALS
      • OPPORTUNITIES
      • CHALLENGES
    • VALUE CHAIN ANALYSIS
    • ECOSYSTEM COVERAGE
    • REGULATORY LANDSCAPE
      • NORTH AMERICA
      • EUROPEAN UNION
      • ASIA PACIFIC
      • REST OF THE WORLD
        • Table NUCLEAR MEDICINE MARKET: REGULATORY LANDSCAPE
    • PORTER'S FIVE FORCES ANALYSIS
      • PORTER'S FIVE FORCES ANALYSIS: NUCLEAR MEDICINE MARKET
      • DEGREE OF COMPETITION
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT FROM SUBSTITUTES
      • THREAT FROM NEW ENTRANTS
    • PIPELINE ANALYSIS
      • Table PIPELINE ANALYSIS
    • PATENT ANALYSIS
      • PATENT PUBLICATION TRENDS FOR NUCLEAR MEDICINE MARKET
    • INDUSTRY TRENDS
      • INCREASING PARTNERSHIPS & COLLABORATIONS FOR INNOVATION
      • GROWING DEMAND FOR PET RADIOPHARMACEUTICALS IN ONCOLOGY AND NEUROLOGY APPLICATIONS
      • ADVANCES IN RESEARCH & DEVELOPMENT OF RADIOPHARMACEUTICALS IN EMERGING COUNTRIES
    • PRICING ANALYSIS
      • Table AVERAGE SELLING PRICE OF RADIOPHARMACEUTICALS, BY TYPE
      • Table AVERAGE SELLING PRICE OF RADIOPHARMACEUTICALS IN EASTERN EUROPE, BY TYPE
      • Table AVERAGE SELLING PRICE OF RADIOPHARMACEUTICALS IN MENAT REGION, BY TYPE
      • AVERAGE SELLING PRICE TREND ANALYSIS
    • KEY CONFERENCES & EVENTS IN 2023-2024
      • Table NUCLEAR MEDICINE MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    • KEY STAKEHOLDERS & BUYING CRITERIA
      • KEY STAKEHOLDERS IN BUYING PROCESS
        • Table INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
      • BUYING CRITERIA
        • Table KEY BUYING CRITERIA FOR END USERS
  • NUCLEAR MEDICINE MARKET, BY TYPE
    • INTRODUCTION
      • Table NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • DIAGNOSTIC NUCLEAR MEDICINE
      • Table DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • SPECT RADIOPHARMACEUTICALS
        • Table ALTERNATIVES TO COMMON TC-99M-BASED DIAGNOSTIC PROCEDURES DUE TO SEVERE TC-99M SHORTAGES
        • Table SPECT RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPECT RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: SPECT RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: SPECT RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: SPECT RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table TC-99M MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: TC-99M MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: TC-99M MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: TC-99M MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table I-123 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: I-123 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: I-123 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: I-123 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table TI-201 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: TI-201 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: TI-201 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: TI-201 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table GA-67 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: GA-67 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: GA-67 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: GA-67 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table OTHER SPECT ISOTOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: OTHER SPECT ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: OTHER SPECT ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: OTHER SPECT ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • PET RADIOPHARMACEUTICALS
        • Table PET RADIOPHARMACEUTICALS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table PET RADIOPHARMACEUTICALS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PET RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PET RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PET RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table F-18 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: F-18 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: F-18 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: F-18 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table RB-82 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: RB-82 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: RB-82 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: RB-82 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table OTHER PET ISOTOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: OTHER PET ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: OTHER PET ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: OTHER PET ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • THERAPEUTIC NUCLEAR MEDICINE
      • Table THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table THERAPEUTIC NUCLEAR MEDICINE MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • ALPHA EMITTERS
        • Table RA-223 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: RA-223 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: RA-223 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: RA-223 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • BETA EMITTERS
        • Table BETA EMITTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table BETA EMITTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: BETA EMITTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: BETA EMITTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: BETA EMITTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table I-131 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: I-131 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: I-131 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: I-131 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table Y-90 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: Y-90 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: Y-90 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: Y-90 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table SM-153 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: SM-153 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: SM-153 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: SM-153 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table LU-177 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: LU-177 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: LU-177 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: LU-177 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table RE-186 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: RE-186 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: RE-186 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: RE-186 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table OTHER BETA EMITTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: OTHER BETA EMITTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: OTHER BETA EMITTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: OTHER BETA EMITTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • BRACHYTHERAPY ISOTOPES
        • Table BRACHYTHERAPY ISOTOPES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRACHYTHERAPY ISOTOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: BRACHYTHERAPY ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: BRACHYTHERAPY ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: BRACHYTHERAPY ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table I-125 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: I-125 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: I-125 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: I-125 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table IR-192 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: IR-192 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: IR-192 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: IR-192 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table PD-103 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: PD-103 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: PD-103 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: PD-103 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table CS-131 MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: CS-131 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: CS-131 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: CS-131 MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table OTHER BRACHYTHERAPY ISOTOPES MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: OTHER BRACHYTHERAPY ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: OTHER BRACHYTHERAPY ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: OTHER BRACHYTHERAPY ISOTOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • NUCLEAR MEDICINE MARKET, BY APPLICATION
    • INTRODUCTION
      • Table NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • DIAGNOSTIC APPLICATIONS
      • Table NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • SPECT APPLICATIONS
        • Table NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY COUNTRY, 2021- 2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR SPECT CARDIOLOGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR SPECT CARDIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR SPECT CARDIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR SPECT CARDIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR SPECT BONE SCAN APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR SPECT BONE SCAN APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR SPECT BONE SCAN APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR SPECT BONE SCAN APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR SPECT THYROID APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR SPECT THYROID APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR SPECT THYROID APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR SPECT THYROID APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR SPECT PULMONARY SCAN APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR SPECT PULMONARY SCAN APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR SPECT PULMONARY SCAN APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR SPECT PULMONARY SCAN APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR OTHER SPECT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR OTHER SPECT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR OTHER SPECT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR OTHER SPECT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • PET APPLICATIONS
        • Table NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR PET ONCOLOGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR PET ONCOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR PET ONCOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR PET ONCOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR PET CARDIOLOGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR PET CARDIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR PET CARDIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR PET CARDIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR PET NEUROLOGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR PET NEUROLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR PET NEUROLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR PET NEUROLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NUCLEAR MEDICINE MARKET FOR OTHER PET APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR OTHER PET APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR OTHER PET APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR OTHER PET APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • THERAPEUTIC APPLICATIONS
      • Table NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • THYROID INDICATIONS
        • Table NUCLEAR MEDICINE MARKET FOR THYROID INDICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR THYROID INDICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR THYROID INDICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR THYROID INDICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • BONE METASTASIS
        • Table NUCLEAR MEDICINE MARKET FOR BONE METASTASIS APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR BONE METASTASIS APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR BONE METASTASIS APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR BONE METASTASIS APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • ENDOCRINE TUMORS
        • Table NUCLEAR MEDICINE MARKET FOR ENDOCRINE TUMOR APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR ENDOCRINE TUMOR APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR ENDOCRINE TUMOR APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR ENDOCRINE TUMOR APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • LYMPHOMA
        • Table NUCLEAR MEDICINE MARKET FOR LYMPHOMA APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR LYMPHOMA APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR LYMPHOMA APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR LYMPHOMA APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
      • OTHER THERAPEUTIC APPLICATIONS
        • Table NUCLEAR MEDICINE MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • NUCLEAR MEDICINE MARKET: PROCEDURAL VOLUME ASSESSMENT
    • INTRODUCTION
      • Table NUCLEAR MEDICINE MARKET, BY PROCEDURE, 2021-2028 (THOUSAND PROCEDURES)
      • Table NUCLEAR MEDICINE MARKET, BY REGION, 2021-2028 (THOUSAND PROCEDURES)
    • DIAGNOSTIC PROCEDURES
      • HIGH PREVALENCE OF CANCER AND CARDIAC DISEASES TO DRIVE MARKET GROWTH
        • Table NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC PROCEDURES, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
        • Table NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC PROCEDURES, BY REGION, 2021-2028 (THOUSAND PROCEDURES)
    • THERAPEUTIC PROCEDURES
      • GROWING DEMAND FOR NON-INVASIVE METHODS TO SUPPORT MARKET GROWTH
        • Table NUCLEAR MEDICINE MARKET FOR THERAPEUTIC PROCEDURES, BY TYPE, 2021-2028 (THOUSAND PROCEDURES)
        • Table NUCLEAR MEDICINE MARKET FOR THERAPEUTIC PROCEDURES, BY REGION, 2021-2028 (THOUSAND PROCEDURES)
  • NUCLEAR MEDICINE MARKET, BY END USER
    • INTRODUCTION
      • Table NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • HOSPITALS
      • RISING TREND OF MODERNIZING IMAGING WORKFLOW TO DRIVE ADOPTION OF IMAGING SYSTEMS IN HOSPITALS
        • Table NUCLEAR MEDICINE MARKET FOR HOSPITALS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
    • IMAGING CENTERS
      • GROWING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH
        • Table NUCLEAR MEDICINE MARKET FOR IMAGING CENTERS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR IMAGING CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR IMAGING CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR IMAGING CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • ACADEMIC & RESEARCH CENTERS
      • INCREASING COLLABORATIONS BETWEEN NUCLEAR IMAGING COMPANIES AND ACADEMIA TO PROPEL MARKET GROWTH
        • Table NUCLEAR MEDICINE MARKET FOR ACADEMIC & RESEARCH CENTERS, BY REGION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR ACADEMIC & RESEARCH CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • OTHER END USERS
      • Table NUCLEAR MEDICINE MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: NUCLEAR MEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • NUCLEAR MEDICINE MARKET, BY REGION
    • INTRODUCTION
      • Table NUCLEAR MEDICINE MARKET, BY REGION, 2021-2028 (USD MILLION)
    • NORTH AMERICA
      • NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021- 2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • US
        • Table US: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
        • Table US: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table US: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • CANADA
        • Table CANADA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
        • Table CANADA: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table CANADA: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • EUROPE
      • EUROPE: IMPACT OF ECONOMIC RECESSION
        • Table EUROPE: NUCLEAR MEDICINE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • GERMANY
        • Table GERMANY: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table GERMANY: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • FRANCE
        • Table FRANCE: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
        • Table FRANCE: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table FRANCE: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • UK
        • Table UK: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table UK: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021- 2028 (USD MILLION)
        • Table UK: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • ITALY
        • Table ITALY: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
        • Table ITALY: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table ITALY: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021- 2028 (USD MILLION)
        • Table ITALY: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • SPAIN
        • Table SPAIN: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table SPAIN: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021- 2028 (USD MILLION)
        • Table SPAIN: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • ASIA PACIFIC
      • ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • JAPAN
        • Table JAPAN: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table JAPAN: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • CHINA
        • Table CHINA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
        • Table CHINA: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table CHINA: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
    • REST OF THE WORLD
      • REST OF THE WORLD: IMPACT OF ECONOMIC RECESSION
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: DIAGNOSTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: THERAPEUTIC NUCLEAR MEDICINE MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET FOR BETA EMITTERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET FOR BRACHYTHERAPY ISOTOPES, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET FOR SPECT APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET FOR PET APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF THE WORLD: NUCLEAR MEDICINE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • STRATEGIES ADOPTED BY KEY PLAYERS
      • Table OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
    • MARKET RANKING ANALYSIS
    • REVENUE ANALYSIS OF KEY MARKET PLAYERS
    • COMPANY EVALUATION MATRIX
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • COMPETITIVE BENCHMARKING
      • OVERALL FOOTPRINT OF KEY PLAYERS
        • Table OVERALL FOOTPRINT OF KEY PLAYERS
        • Table REGIONAL FOOTPRINT OF KEY PLAYERS
        • Table TYPE FOOTPRINT OF KEY PLAYERS
    • COMPETITIVE SCENARIO
      • PRODUCT APPROVALS & ENHANCEMENTS
        • Table KEY PRODUCT APPROVALS & ENHANCEMENTS
      • DEALS
        • Table KEY DEALS
      • OTHER DEVELOPMENTS
        • Table KEY OTHER DEVELOPMENTS
  • COMPANY PROFILES
    • MAJOR PLAYERS
      • GE HEALTHCARE
        • Table GE HEALTHCARE: BUSINESS OVERVIEW
      • CARDINAL HEALTH
        • Table CARDINAL HEALTH: BUSINESS OVERVIEW
      • CURIUM
        • Table CURIUM: BUSINESS OVERVIEW
      • BAYER AG
        • Table BAYER AG: BUSINESS OVERVIEW
      • LANTHEUS HOLDINGS, INC.
        • Table LANTHEUS HOLDINGS, INC.: BUSINESS OVERVIEW
      • BRACCO IMAGING S.P.A.
        • Table BRACCO IMAGING S.P.A.: BUSINESS OVERVIEW
      • PHARMALOGIC HOLDINGS CORP.
        • Table PHARMALOGIC HOLDINGS CORP.: BUSINESS OVERVIEW
      • ECZACIBAªI-MONROL NUCLEAR PRODUCTS
        • Table ECZACIBAªI-MONROL NUCLEAR PRODUCTS: BUSINESS OVERVIEW
      • NTP RADIOISOTOPES SOC LTD. (A SUBSIDIARY OF SOUTH AFRICAN NUCLEAR ENERGY CORPORATION)
        • Table NTP RADIOISOTOPES SOC LTD.: BUSINESS OVERVIEW
      • NORDION INC.
        • Table NORDION INC.: BUSINESS OVERVIEW
      • ADVANCED ACCELERATOR APPLICATIONS (A NOVARTIS COMPANY)
        • Table ADVANCED ACCELERATOR APPLICATIONS: BUSINESS OVERVIEW
      • NORTHSTAR MEDICAL RADIOISOTOPES
        • Table NORTHSTAR MEDICAL RADIOISOTOPES: BUSINESS OVERVIEW
      • ECKERT & ZIEGLER
        • Table ECKERT & ZIEGLER: BUSINESS OVERVIEW
      • ISOTOPE JSC
        • Table JOINT STOCK COMPANY ISOTOPE (ISOTOPE JSC): BUSINESS OVERVIEW
      • SIEMENS HEALTHINEERS
        • Table SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
      • JUBILANT DRAXIMAGE, INC. (A SUBSIDIARY OF JUBILANT PHARMA)
        • Table JUBILANT DRAXIMAGE, INC.: BUSINESS OVERVIEW
    • OTHER PLAYERS
      • GLOBAL MEDICAL SOLUTIONS
      • SHINE TECHNOLOGIES, LLC
      • ISOTOPIA MOLECULAR IMAGING LTD.
      • BWXT MEDICAL LTD.
      • INSTITUTE OF ISOTOPES
      • CHINA ISOTOPE & RADIATION CORPORATION
      • YANTAI DONGCHENG PHARMACEUTICAL GROUP CO., LTD.
      • CYCLOPHARM
      • IRE ELIT
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings